Jan Oosting
Overview
Explore the profile of Jan Oosting including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
1279
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oosting J
J Nurs Educ
. 2024 Jul;
:1-4.
PMID: 39038817
Background: Translanguaging is "the act performed by bilinguals of accessing different linguistic features or various modes of what are described as autonomous languages in order to maximize communicative potential" (Skutnabb-Kangas...
2.
Jamieson A, Vermij L, Kramer C, Jobsen J, Jurgemlienk-Schulz I, Lutgens L, et al.
Clin Cancer Res
. 2023 Sep;
29(23):4949-4957.
PMID: 37773079
Purpose: The clinical significance of the p53-abnormal (p53abn) molecular subtype in stage I low-grade endometrioid endometrial carcinoma (EEC) is debated. We aimed to review pathologic and molecular characteristics, and outcomes...
3.
Oosting J
J Nurs Educ
. 2023 Jul;
62(10):584-588.
PMID: 37459207
Background: The lesbian, gay, bisexual, transgender, and queer or questioning (LGBTQ+) community faces discrimination in health care. Nurses interact with LGBTQ+ individuals in a wide variety of health care settings....
4.
Brouwer T, Ijsselsteijn M, Oosting J, Ruano D, van der Ploeg M, Dijk F, et al.
Cancers (Basel)
. 2022 Aug;
14(16).
PMID: 36010856
Pancreatic ductal adenocarcinoma (PDAC) is considered to be a poorly immunogenic cancer type that combines a low mutation burden with a strong immunosuppressive tumor microenvironment. Regulatory T cells (Tregs) are...
5.
Silva A, Saito Y, Yoshikawa T, Oshima T, Hayden J, Oosting J, et al.
Br J Surg
. 2022 May;
109(9):e106.
PMID: 35554502
No abstract available.
6.
Silva A, Saito Y, Yoshikawa T, Oshima T, Hayden J, Oosting J, et al.
Br J Surg
. 2022 Feb;
109(3):291-297.
PMID: 35179206
Background: Patients with Epstein-Barr virus-positive gastric cancers or those with microsatellite instability appear to have a favourable prognosis. However, the prognostic value of the chromosomal status (chromosome-stable (CS) versus chromosomal...
7.
Rademaker E, Bastiaannet E, Oosting J, Dekker-Ensink N, Kuppen P, de Miranda N, et al.
J Gastrointest Cancer
. 2022 Feb;
54(1):147-154.
PMID: 35112314
Purpose: Integrin subunit β4 (β4) has been proposed to play an important role in colon cancer progression through its involvement in hemidesmosome disassembly processes and tumor cell migration. However, the...
8.
Franceschini N, Oosting J, Tamsma M, Niessen B, Briaire-de Bruijn I, van den Akker B, et al.
Int J Mol Sci
. 2021 Jul;
22(12).
PMID: 34200964
For osteosarcoma (OS), the most common primary malignant bone tumor, overall survival has hardly improved over the last four decades. Especially for metastatic OS, novel therapeutic targets are urgently needed....
9.
Aydemirli M, van Eendenburg J, van Wezel T, Oosting J, Corver W, Kapiteijn E, et al.
Endocr Relat Cancer
. 2021 Apr;
28(6):377-389.
PMID: 33878728
Finding targetable gene fusions can expand the limited treatment options in radioactive iodine-refractory (RAI-r) thyroid cancer. To that end, we established a novel cell line 'JVE404' derived from an advanced...
10.
Vermij L, Singh N, Leon-Castillo A, Horeweg N, Oosting J, Carlson J, et al.
Histopathology
. 2021 Apr;
79(4):533-543.
PMID: 33835523
Aims: Human epidermal growth factor receptor 2 (HER2) amplification in endometrial cancer (EC) is almost completely confined to the p53-abnormal (p53abn) molecular subtype and independent of histological subtype. HER2 testing...